Skip to main content
Supplement ScienceSupplementScience

Benefits of DIM (Diindolylmethane)

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Estrogen metabolism modulation — DIM increases CYP1A1/CYP1A2 activity, shifting estrogen metabolism toward 2-hydroxyestrone (2-OHE1), a less proliferative metabolite, and away from 16α-hydroxyestrone (16α-OHE1) and 4-hydroxyestrone (4-OHE1). Dalessandri et al. (2004, n=19) demonstrated improved 2:16α-OHE1 ratios in postmenopausal women with early-stage cervical dysplasia taking 200mg BioResponse DIM.
  • Liver detoxification enzyme induction — DIM activates the aryl hydrocarbon receptor (AhR), inducing Phase I enzymes (CYP1A1, CYP1A2, CYP1B1) and Phase II enzymes (glutathione S-transferases, NQO1) in hepatocytes (Bjeldanes et al., 1991).
  • Anti-proliferative effects — DIM inhibits cell proliferation and induces apoptosis in hormone-sensitive cancer cell lines (breast, prostate, cervical). A Phase I clinical trial by Reed et al. (2005, n=12) showed DIM was well-tolerated at 300mg/day with evidence of anti-proliferative biomarker changes.
  • Androgen receptor modulation — DIM acts as an androgen receptor antagonist and may support healthy testosterone metabolism in men, relevant to prostate health (Le et al., 2003).
  • NF-κB inhibition — DIM reduces NF-κB-mediated inflammatory signaling, providing anti-inflammatory effects in both liver and systemic tissues (Li et al., 2005).

What the Research Says

DIM is the most biologically relevant metabolite of indole-3-carbinol from cruciferous vegetables. Dalessandri et al. (2004) provided key clinical evidence showing DIM supplementation improves the 2:16α-hydroxyestrone ratio in women, supporting favorable estrogen metabolism. Bjeldanes et al. (1991) established the mechanistic basis for DIM's induction of Phase I and Phase II detoxification enzymes through AhR activation. Reed et al. (2005) demonstrated safety and preliminary efficacy in a Phase I cancer prevention trial. A major practical consideration is bioavailability: crystalline DIM is extremely poorly absorbed, and the BioResponse microencapsulated formulation used in most clinical trials provides dramatically superior absorption. Most supplement research and clinical applications use the BioResponse delivery system.

Related Conditions

Liver HealthAcneHormonal ImbalancePcos
Ready to try DIM (Diindolylmethane)?
See our independently tested and ranked picks
Full DIM (Diindolylmethane) Guide

References

  1. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF (2004). Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutrition and Cancer. DOI PubMed
  2. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA (1991). Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proceedings of the National Academy of Sciences. DOI PubMed
  3. Reed GA, Sunega JM, Sullivan DK, Gray JC, Mayo MS, Crowell JA, Hurwitz A (2005). Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects. Cancer Epidemiology, Biomarkers & Prevention. DOI PubMed
  4. Le HT, Schaldach CM, Bheldanes LF, Firestone GL (2003). Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. Journal of Biological Chemistry. DOI PubMed